HOLLY SHIVELY: Open Payments
NPI 1508136359 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$363 in 15 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $202 · 2025 $363
Food & beverage: $363
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 5 | $104 |
| Sumitomo Pharma America, Inc. | 2 | $90 |
| Exeltis, USA Inc. | 3 | $53 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $47 |
| Organon LLC | 1 | $25 |
| Hologic Sales and Service, LLC | 1 | $23 |
| MILLICENT US INC | 1 | $21 |
Products named: Veozah, MYFEMBREE, SLYND, Lynkuet, NEXPLANON, APTIMA, Mirena, INTRAROSA.
Industry payments across FL — which companies pay providers there.
